202 related articles for article (PubMed ID: 16598106)
21. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.
Minutello RM; Bhagan S; Sharma A; Slotwiner AJ; Feldman DN; Cuomo LJ; Wong SC
J Interv Cardiol; 2007 Dec; 20(6):458-65. PubMed ID: 18042050
[TBL] [Abstract][Full Text] [Related]
22. Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis.
Ko DT; Chiu M; Austin PC; Bowen J; Cohen EA; Tu JV
Am Heart J; 2008 Jul; 156(1):125-34. PubMed ID: 18585507
[TBL] [Abstract][Full Text] [Related]
23. Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry.
Dou KF; Xu B; Yang YJ; Chen JL; Qiao SB; Li JJ; Qin XW; Liu HB; Wu YJ; Chen J; Yao M; You SJ; Yuan JQ; Dai J; Gao RL
Chin Med J (Engl); 2009 Mar; 122(6):612-6. PubMed ID: 19323921
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous intervention on the saphenous vein bypass grafts--long-term outcomes.
Bansal D; Muppidi R; Singla S; Sukhija R; Zarich S; Mehta JL; Sachdeva R
Catheter Cardiovasc Interv; 2008 Jan; 71(1):58-61. PubMed ID: 18098183
[TBL] [Abstract][Full Text] [Related]
25. Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program.
Lasala JM; Cox DA; Morris DL; Breall JA; Mahoney PD; Horwitz PA; Shaw D; Hood KL; Mandinov L; Dawkins KD
Am J Cardiol; 2009 Jun; 103(12):1663-71. PubMed ID: 19539073
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of drug-eluting and bare metal stents in saphenous vein grafts. Immediate and long-term results].
Lozano I; García-Camarero T; Carrillo P; Baz JA; de la Torre JM; López-Palop R; Pinar E; Salvatella N; Avanzas P; Valdés M
Rev Esp Cardiol; 2009 Jan; 62(1):39-47. PubMed ID: 19150013
[TBL] [Abstract][Full Text] [Related]
27. Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention.
Zhang RY; Ni JW; Zhang JS; Hu J; Yang ZK; Zhang Q; Lü AK; Shen WF
Chin Med J (Engl); 2006 Jul; 119(14):1176-81. PubMed ID: 16863609
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694
[TBL] [Abstract][Full Text] [Related]
29. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.
Cohen DJ; Murphy SA; Baim DS; Lavelle TA; Berezin RH; Cutlip DE; Ho KK; Kuntz RE;
J Am Coll Cardiol; 2004 Nov; 44(9):1801-8. PubMed ID: 15519010
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention.
Chu WW; Rha SW; Kuchulakanti PK; Cheneau E; Torguson R; Pinnow E; Alexieva-Fournadjiev J; Pichard AD; Satler LF; Kent KM; Lindsay J; Waksman R
Am J Cardiol; 2006 Jan; 97(1):34-7. PubMed ID: 16377280
[TBL] [Abstract][Full Text] [Related]
32. Long-term clinical outcomes after bioabsorbable polymer- and durable polymer-based sirolimus-eluting stents implantation: two-year follow-up results from a large single-center database.
Liu HB; Xu B; Yang YJ; Wang Y; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Ma WH; Li JJ; Qiao SB; Chen JL; Li W; Gao RL
Chin Med J (Engl); 2009 Mar; 122(6):681-6. PubMed ID: 19323934
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcome of patients with diabetes mellitus and chronic total occlusion treated with drug-eluting stents.
De Felice F; Fiorilli R; Parma A; Nazzaro MS; Dibra A; Musto C; De Santis A; Violini R
J Invasive Cardiol; 2008 Dec; 20(12):651-4. PubMed ID: 19057029
[TBL] [Abstract][Full Text] [Related]
34. Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease.
Sheiban I; Garrone P; Sillano D; Biondi-Zoccai G; Sciuto F; Omedè P; Lombardi P; Meliga E; Anselmino M; Trevi GP; Moretti C
J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1246-53. PubMed ID: 19001932
[TBL] [Abstract][Full Text] [Related]
35. Influence of diabetes and bilateral internal thoracic artery grafts on long-term outcome for multivessel coronary artery bypass grafting.
Stevens LM; Carrier M; Perrault LP; Hébert Y; Cartier R; Bouchard D; Fortier A; Pellerin M
Eur J Cardiothorac Surg; 2005 Feb; 27(2):281-8. PubMed ID: 15691683
[TBL] [Abstract][Full Text] [Related]
36. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
Pedersen SS; Denollet J; Ong AT; Sonnenschein K; Erdman RA; Serruys PW; van Domburg RT
Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):135-40. PubMed ID: 17301639
[TBL] [Abstract][Full Text] [Related]
37. Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients.
Billinger M; Beutler J; Taghetchian KR; Remondino A; Wenaweser P; Cook S; Togni M; Seiler C; Stettler C; Eberli FR; Lüscher TF; Wandel S; Jüni P; Meier B; Windecker S
Eur Heart J; 2008 Mar; 29(6):718-25. PubMed ID: 18272504
[TBL] [Abstract][Full Text] [Related]
38. Comparison of outcomes of percutaneous coronary intervention on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: a cross-sectional study.
Alidoosti M; Salarifar M; Zeinali AM; Kassaian SE; Dehkordi MR
BMC Cardiovasc Disord; 2007 Mar; 7():7. PubMed ID: 17335586
[TBL] [Abstract][Full Text] [Related]
39. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention.
Nikolsky E; Mehran R; Turcot D; Aymong ED; Mintz GS; Lasic Z; Lansky AJ; Tsounias E; Moses JW; Stone GW; Leon MB; Dangas GD
Am J Cardiol; 2004 Aug; 94(3):300-5. PubMed ID: 15276092
[TBL] [Abstract][Full Text] [Related]
40. Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: trends over time.
Champney KP; Veledar E; Klein M; Samady H; Anderson D; Parashar S; Wenger N; Vaccarino V
Am Heart J; 2007 Jun; 153(6):970-8. PubMed ID: 17540197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
